JTM

official impact factor 3.51

Open Access Highly Access

Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine

Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Alma Chavez-Blanco, Alma Revilla-Vazquez, Luis Benitez-Bribiesca and Alfonso Duenas-González*

Journal of Translational Medicine 2006, 4:32 doi:10.1186/1479-5876-4-32

Accesses  

  • Last 30 days: 76 accesses
  • Last 365 days: 700 accesses
  • All time: 4894 accesses

Cited by